Successful prevention of recurrent anaphylactic events with anti-immunoglobulin E therapy.Anaphylaxis is a fatal and systemic allergic reaction, which can be prevented by avoiding exposure to a causative agent.  Anti-immunoglobulin E (IgE) therapy was introduced to prevent further anaphylactic events. 
anti-immunoglobulin E
We report a patient who experienced recurrent anaphylactic events that were prevented effectively by anti-IgE therapy with omalizumab. 
omalizumab